Publication

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization

Related publications (37)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization

Graph Chatbot

Chat with Graph Search

Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys

Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma

Cell-free method for the quantitative measurement of virus neutralizing antibodies

A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity

Initial Step of Virus Entry: Virion Binding to Cell-Surface Glycans

How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

Expanding beyond the natural protein repertoire to engineer targeted vaccines and diagnostics